Dermal Filler Vascular Occlusion: Signs, Early Recognition and Emergency Management

Vascular occlusion is the interruption of blood flow caused by filler being injected into a vessel or compressing one from outside. It is the rarest but most serious complication of dermal fillers and is a medical emergency. Early recognition (within the first hours) and, for hyaluronic acid fillers, prompt treatment with the enzyme hyaluronidase can largely prevent tissue loss and permanent damage. This guide helps patients recognise the warning signs and explains the physician's management logic.

What is vascular occlusion?

The face has a dense vascular network. If the needle or cannula tip enters an artery (or vein) during injection, or if a high volume placed in the surrounding tissue compresses a vessel, blood flow to the area that vessel supplies stops. Skin and tissue deprived of supply begin to suffer within hours. The highest-risk areas — the glabella (between the brows), the nose, the nasolabial region and around the lips — are especially vulnerable because of the face's end-artery supply.

Vascular occlusion is rare; however, because of its severity, every injector must be competent in recognising and managing it.

Early warning signs (for patients and physicians)

The following findings, especially in combination and appearing during or immediately after injection, should be evaluated for vascular occlusion:

• Disproportionate, severe pain — beyond normal filler tenderness, sharp and persistent.
• Sudden blanching — whitening/paling of the skin at the injection site or in the area the vessel supplies.
• Livedo / mottled discolouration — a net-like, purplish-grey colour change.
• Delayed capillary refill — colour returning more slowly than normal when the skin is pressed.
• Coldness, numbness, and in later hours blistering or darkening.
• In treatments near the eye, vision changes / sudden vision loss, severe eye pain — this is the most urgent picture (retinal artery occlusion); seek an ophthalmologist/emergency care immediately.

Why is early recognition critical?

Tissue ischaemia (loss of blood supply) is a window measured in hours. The earlier the intervention, the higher the chance of saving tissue. This is why both the physician's vigilance during the procedure and the patient's awareness of warning signs in the first hours and days are essential.

Management logic (physician perspective)

The following is a general clinical framework; the actual approach depends on the product type and the case, and is carried out only by a physician:

• Stop the injection and assess the area.
• For hyaluronic acid fillers, hyaluronidase — the enzyme that dissolves HA filler; in suspected occlusion, adequate dosing along the affected vessel, repeated if needed, is essential.
• Warm compress and massage to support vasodilation and dispersion.
• Additional supportive measures and, where appropriate, referral to a higher centre.
• Close follow-up — hourly/daily perfusion assessment and photographic documentation.

Principles that reduce risk

• An experienced physician with sound anatomical knowledge and appropriate technique (aspiration, cannula choice, slow low-pressure injection, small aliquots).
• Extra care in high-risk areas.
• Keeping hyaluronidase and an emergency protocol ready in the clinic — a standard of safe practice.

Our Clinic's Approach